140911-31-5

Basic information

• Product Name: 8-CHLORO-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-A]PYRAZINE
• Synonyms: 8-CHLORO-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-A]PYRAZINE;1,2,4-TRIAZOLO[4,3-A]PYRAZINE, 8-CHLORO-3-(TRIFLUOROMETHYL)-;8-chloro-3-(trifluoroMethyl)-[1;8-Chloro-3-(trifluoromethyl)triazolo[4,3-a]pyrazine;5-chloro-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrazine
• CAS NO: 140911-31-5
• Molecular Formula: C₆H₂ClF₃N₄
• Molecular Weight: 222.56
• Mol File: 140911-31-5.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 8-CHLORO-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-A]PYRAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 8-CHLORO-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-A]PYRAZINE(140911-31-5)
• EPA Substance Registry System: 8-CHLORO-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-A]PYRAZINE(140911-31-5)

Safety Data

• Hazardous Substances Data: 140911-31-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
8-CHLORO-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-A]PYRAZINE is used as a building block for the development of pharmaceuticals due to its unique chemical and biological properties. Its presence in the triazolopyrazine family allows for the creation of compounds with diverse pharmacological activities, making it a promising candidate for various therapeutic applications.
Used in Agrochemical Industry:
8-CHLORO-3-(TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3-A]PYRAZINE is used as a building block for the development of agrochemicals, leveraging its unique properties to create compounds with potential applications in agriculture, such as pesticides or herbicides. Its role in this industry is to contribute to the creation of effective and environmentally friendly solutions for crop protection and management.

Upstream product

• 877402-74-9 3-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyrazine 7-oxide 

Relevant articles and documents

Triazolo pyrazine compound containing heteroaryl substituted pyridazinone structure, and preparation method and applications thereof

The invention relates to a triazolo pyrazine compound containing a heteroaryl substituted pyridazinone structure, and pharmaceutically acceptable salts, hydrates, solvates, and a prodrug thereof, wherein the triazolo pyrazine compound containing a heteroa

BICYCLIC AZAHETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS

Disclosed are chemical entities of Formula (I): wherein R1 and Z are defined herein, as NR2B subtype selective receptor antagonists. Also disclosed are pharmaceutical compositions comprising a chemical entity of Formula (I), and methods of treating various diseases and disorders associated with NR2B antagonism, e.g., diseases and disorders of the CNS, such as depression, by administering a chemical entity of Formula (I).

FUSED TRIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

The present invention is directed to novel fused triazole derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DPP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.